Raleigh biotech targeting cancer raises $37M, plans to triple headcount

The Raleigh-based company will further its effort to develop cell therapy treatments targeting difficult-to-treat cancers.

Source: bizjournals.com Health Care:Physician Practices headlines - May 19, 2022 Category: American Health Authors: Zac Ezzone Source Type: news